Cargando…
Pharmacological Potential of Lathyrane-Type Diterpenoids from Phytochemical Sources
Lathyrane diterpenoids are one of the primary types of secondary metabolites present in the genus Euphorbia and one of the largest groups of diterpenes. They are characterized by having a highly oxygenated tricyclic system of 5, 11 and 3 members. These natural products and some synthetic derivatives...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318715/ https://www.ncbi.nlm.nih.gov/pubmed/35890079 http://dx.doi.org/10.3390/ph15070780 |
_version_ | 1784755359110397952 |
---|---|
author | Vela, Fátima Ezzanad, Abdellah Hunter, Alan Christy Macías-Sánchez, Antonio José Hernández-Galán, Rosario |
author_facet | Vela, Fátima Ezzanad, Abdellah Hunter, Alan Christy Macías-Sánchez, Antonio José Hernández-Galán, Rosario |
author_sort | Vela, Fátima |
collection | PubMed |
description | Lathyrane diterpenoids are one of the primary types of secondary metabolites present in the genus Euphorbia and one of the largest groups of diterpenes. They are characterized by having a highly oxygenated tricyclic system of 5, 11 and 3 members. These natural products and some synthetic derivatives have shown numerous interesting biological activities with clinical potential against various diseases, such as cytotoxic activity against cancer cell lines, multi-drug resistance reversal, antiviral properties, anti-inflammatory activity and their capability to induce proliferation or differentiation into neurons of neural progenitor cells. The structure of the lathyrane skeleton could be considered privileged because its framework is able to direct functional groups in a well-defined space. The favorable arrangement of these makes interaction possible with more than one target. This review aims to highlight the evidence of lathyranes as privileged structures in medicinal chemistry. Chemical structures of bioactive compounds, the evaluation of biological properties of natural and semisynthetic derivatives, and the exploration of the mechanisms of action as well as target identification and some aspects of their targeted delivery are discussed. |
format | Online Article Text |
id | pubmed-9318715 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93187152022-07-27 Pharmacological Potential of Lathyrane-Type Diterpenoids from Phytochemical Sources Vela, Fátima Ezzanad, Abdellah Hunter, Alan Christy Macías-Sánchez, Antonio José Hernández-Galán, Rosario Pharmaceuticals (Basel) Review Lathyrane diterpenoids are one of the primary types of secondary metabolites present in the genus Euphorbia and one of the largest groups of diterpenes. They are characterized by having a highly oxygenated tricyclic system of 5, 11 and 3 members. These natural products and some synthetic derivatives have shown numerous interesting biological activities with clinical potential against various diseases, such as cytotoxic activity against cancer cell lines, multi-drug resistance reversal, antiviral properties, anti-inflammatory activity and their capability to induce proliferation or differentiation into neurons of neural progenitor cells. The structure of the lathyrane skeleton could be considered privileged because its framework is able to direct functional groups in a well-defined space. The favorable arrangement of these makes interaction possible with more than one target. This review aims to highlight the evidence of lathyranes as privileged structures in medicinal chemistry. Chemical structures of bioactive compounds, the evaluation of biological properties of natural and semisynthetic derivatives, and the exploration of the mechanisms of action as well as target identification and some aspects of their targeted delivery are discussed. MDPI 2022-06-23 /pmc/articles/PMC9318715/ /pubmed/35890079 http://dx.doi.org/10.3390/ph15070780 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Vela, Fátima Ezzanad, Abdellah Hunter, Alan Christy Macías-Sánchez, Antonio José Hernández-Galán, Rosario Pharmacological Potential of Lathyrane-Type Diterpenoids from Phytochemical Sources |
title | Pharmacological Potential of Lathyrane-Type Diterpenoids from Phytochemical Sources |
title_full | Pharmacological Potential of Lathyrane-Type Diterpenoids from Phytochemical Sources |
title_fullStr | Pharmacological Potential of Lathyrane-Type Diterpenoids from Phytochemical Sources |
title_full_unstemmed | Pharmacological Potential of Lathyrane-Type Diterpenoids from Phytochemical Sources |
title_short | Pharmacological Potential of Lathyrane-Type Diterpenoids from Phytochemical Sources |
title_sort | pharmacological potential of lathyrane-type diterpenoids from phytochemical sources |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318715/ https://www.ncbi.nlm.nih.gov/pubmed/35890079 http://dx.doi.org/10.3390/ph15070780 |
work_keys_str_mv | AT velafatima pharmacologicalpotentialoflathyranetypediterpenoidsfromphytochemicalsources AT ezzanadabdellah pharmacologicalpotentialoflathyranetypediterpenoidsfromphytochemicalsources AT hunteralanchristy pharmacologicalpotentialoflathyranetypediterpenoidsfromphytochemicalsources AT maciassanchezantoniojose pharmacologicalpotentialoflathyranetypediterpenoidsfromphytochemicalsources AT hernandezgalanrosario pharmacologicalpotentialoflathyranetypediterpenoidsfromphytochemicalsources |